NDAINTRAVENOUSSOLUTION
Approved
May 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
INFUVITE ADULT (multiple vitamins injection) by Novartis. Approved for vitamin deficiency in adults, children aged 11, older receiving parenteral nutrition (). First approved in 2000.
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
INFUVITE ADULT is an intravenous multiple vitamins injection used to treat vitamin deficiency in adults and children aged 11+, particularly those receiving parenteral nutrition. It is a nutritional supplement solution containing essential vitamins for systemic supplementation.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), suggesting defending market share will require focused commercial efforts.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on INFUVITE ADULT at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.